We first determined if activation of endogenous CXCR4 by stromal cell–derived factor 1α (SDF1α) could activate ARF1 in human androgen–insensitive prostate cancer (DU145 and PC3) cells and human embryonic kidney 293 (HEK293) cells. Here, CXCR4 is linked to prostate carcinoma.